HAXIDIA 5 - CÔNG TY CỔ PHẦN GLOBAL PHARMACEUTICAL

HAXIDIA 5 - CÔNG TY CỔ PHẦN GLOBAL PHARMACEUTICAL

HAXIDIA 5 - CÔNG TY CỔ PHẦN GLOBAL PHARMACEUTICAL

HAXIDIA 5 - CÔNG TY CỔ PHẦN GLOBAL PHARMACEUTICAL

global pharmaceutical

GLOBAL PHARMACEUTICAL JOINT-STOCK COMPANY

TAKE CARE OF COMMUNITY HEALTH

 global pharmaceutical
Advice and support

0981314599

HAXIDIA 5
HAXIDIA 5

HAXIDIA 5

Packaging

Box of 3 blisters x 10 tablets.

Active ingredient / content:

Active ingredient: Glipizid 5 mg

treatment indications

Non-insulin dependent diabetes mellitus (type 2), when hyperglycemia cannot be controlled by diet and exercise alone.
   
DETAIL

HAXIDIA 5

INDICATIONS:
Non-insulin-dependent diabetes mellitus (type 2), when hyperglycemia cannot be controlled by diet and exercise.

CONTRAINDICATIONS:
Hypersensitivity to glipizide, other sulfonylureas or sulfonamides or to any of the excipients.
Insulin-dependent type 1 diabetes mellitus, especially juvenile diabetes, diabetic ketoacidosis, diabetic pre-coma.
Severe renal or hepatic impairment.
Patients being treated with miconazole.
Surgery, pregnancy, lactation: Insulin replacement is required.

DOSAGE:
Like other hypoglycemic drugs, the dosage must be adjusted for each patient.
Take once in the morning. Take about 30 minutes before meals to minimize postprandial blood glucose levels.

OTHER PRODUCTS
HOT NEWS
SHAREHOLDERS NEWS